Baar, Switzerland
medmix positions itself as a distinguished player in the realm of high-precision delivery devices, serving the healthcare, consumer, and industrial sectors. Founded in 2006 and headquartered in Switzerland, the company has established a global presence with 14 production sites and a dynamic workforce of nearly 2,600 employees.
Central to medmix's value proposition is its commitment to innovation, boasting an impressive portfolio of over 900 active patents. This dedication underscores its leadership in technological advancement, enhancing its appeal in high-tech sectors. The company is publicly traded on the SIX Swiss Exchange under the ticker MEDX, emphasizing its stature and market credibility.
Though not recently funded, medmix's robust operational framework and strategic market positioning make it a compelling candidate for potential investors seeking opportunities in cutting-edge medical devices and precision manufacturing. With a clear vision for quality and agility, medmix is poised for sustained growth and innovation.
